Xiaodong Wang insider trades: BeOne Medicines (ONC) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Xiaodong reports to the SEC
Open-market buys and sales
56 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 27, 2026 | ONC | ↓ Sell | 31,028 | $362.97 | $11.3M | Direct | Oct 29, 2026 (2d) |
| Oct 13, 2026 | ONC | ↓ Sell | 31,027 | $350.99 | $10.9M | Direct | Oct 15, 2026 (2d) |
| Sep 28, 2026 | ONC | ↓ Sell | 31,028 | $364.79 | $11.3M | Direct | Sep 30, 2026 (2d) |
| Jun 24, 2025 | ONC | ↓ Sell | 2,007 | $265.50 | $533K | Direct | Jun 25, 2025 (1d) |
| Jun 10, 2025 | ONC | ↓ Sell | 41,760 | $262.82 | $11.0M | Direct | Jun 12, 2025 (2d) |
| May 13, 2025 | BGNE | ↓ Sell | 41,760 | $223.50 | $9.3M | Direct | May 15, 2025 (2d) |
| Apr 14, 2025 | BGNE | ↓ Sell | 41,760 | $242.66 | $10.1M | Direct | Apr 16, 2025 (2d) |
| Mar 18, 2025 | BGNE | ↓ Sell | 41,760 | $261.28 | $10.9M | Direct | Mar 20, 2025 (2d) |
| Mar 4, 2025 | BGNE | ↓ Sell | 8,146 | $254.58 | $2.1M | Indirect | Mar 6, 2025 (2d) |
| Feb 4, 2025 | BGNE | ↓ Sell | 41,760 | $225.69 | $9.4M | Direct | Feb 6, 2025 (2d) |
| Jan 7, 2025 | BGNE | ↓ Sell | 41,760 | $176.50 | $7.4M | Direct | Jan 8, 2025 (1d) |
| Dec 10, 2024 | BGNE | ↓ Sell | 41,760 | $186.90 | $7.8M | Direct | Dec 12, 2024 (2d) |
| Nov 26, 2024 | BGNE | ↓ Sell | 40,468 | $190.10 | $7.7M | Direct | Nov 29, 2024 (3d) |
| Nov 26, 2024 | BGNE | ↓ Sell | 7,883 | $189.97 | $1.5M | Indirect | Nov 29, 2024 (3d) |
| Mar 8, 2023 | BGNE | ↓ Sell | 67,635 | $226.03 | $15.3M | Direct | Mar 10, 2023 (2d) |
| Jan 12, 2023 | BGNE | ↓ Sell | 5,000 | $260.52 | $1.3M | Indirect | Jan 17, 2023 (5d) |
| Jan 11, 2023 | BGNE | ↓ Sell | 5,000 | $251.36 | $1.3M | Direct | Jan 11, 2023 (0d) |
| Dec 13, 2022 | BGNE | ↓ Sell | 3,013 | $211.33 | $637K | Indirect | Dec 15, 2022 (2d) |
| Nov 15, 2022 | BGNE | ↓ Sell | 1,987 | $210.14 | $418K | Indirect | Nov 17, 2022 (2d) |
| Aug 8, 2022 | BGNE | ↓ Sell | 11,060 | $197.91 | $2.2M | Direct | Aug 9, 2022 (1d) |
| Aug 5, 2022 | BGNE | ↓ Sell | 5,000 | $193.85 | $969K | Indirect | Aug 9, 2022 (4d) |
| Nov 8, 2021 | BGNE | ↓ Sell | 4,500 | $350.04 | $1.6M | Direct | Nov 10, 2021 (2d) |
| Nov 8, 2021 | BGNE | ↓ Sell | 4,500 | $349.81 | $1.6M | Direct | Nov 10, 2021 (2d) |
| Jul 1, 2021 | BGNE | ↓ Sell | 4,848 | $348.15 | $1.7M | Direct | Jul 1, 2021 (0d) |
| May 10, 2021 | BGNE | ↓ Sell | 3,394 | $300.46 | $1.0M | Direct | May 12, 2021 (2d) |
| Oct 16, 2020 | BGNE | ↓ Sell | 5,000 | $320.00 | $1.6M | Indirect | Oct 20, 2020 (4d) |
| Oct 5, 2020 | BGNE | ↓ Sell | 5,000 | $300.00 | $1.5M | Indirect | Oct 7, 2020 (2d) |
| Sep 25, 2020 | BGNE | ↓ Sell | 5,000 | $280.42 | $1.4M | Indirect | Sep 29, 2020 (4d) |
| Sep 17, 2020 | BGNE | ↓ Sell | 5,000 | $260.27 | $1.3M | Indirect | Sep 21, 2020 (4d) |
| Aug 10, 2020 | BGNE | ↓ Sell | 4,000 | $211.06 | $844K | Indirect | Aug 12, 2020 (2d) |
| Jul 20, 2020 | BGNE | ↓ Sell | 12,000 | $251.31 | $3.0M | Indirect | Jul 22, 2020 (2d) |
| Jul 20, 2020 | BGNE | ↓ Sell | 5,000 | $251.98 | $1.3M | Direct | Jul 22, 2020 (2d) |
| Jul 7, 2020 | BGNE | ↓ Sell | 6,000 | $200.00 | $1.2M | Indirect | Jul 9, 2020 (2d) |
| Jul 1, 2020 | BGNE | ↓ Sell | 4,847 | $190.75 | $925K | Direct | Jul 6, 2020 (5d) |
| Jun 23, 2020 | BGNE | ↓ Sell | 6,000 | $186.38 | $1.1M | Indirect | Jun 24, 2020 (1d) |
| Jun 22, 2020 | BGNE | ↓ Sell | 5,000 | $181.33 | $907K | Direct | Jun 24, 2020 (2d) |
| Jun 8, 2020 | BGNE | ↓ Sell | 6,000 | $170.91 | $1.0M | Direct | Jun 10, 2020 (2d) |
| Mar 4, 2020 | BGNE | ↓ Sell | 5,000 | $157.14 | $786K | Direct | Mar 6, 2020 (2d) |
| Nov 15, 2019 | BGNE | ↓ Sell | 10,000 | $194.61 | $1.9M | Direct | Nov 18, 2019 (3d) |
| Nov 15, 2019 | BGNE | ↓ Sell | 3,000 | $194.68 | $584K | Indirect | Nov 18, 2019 (3d) |
| Nov 4, 2019 | BGNE | ↓ Sell | 2,000 | $180.00 | $360K | Direct | Nov 5, 2019 (1d) |
| Jul 1, 2019 | BGNE | ↓ Sell | 4,847 | $126.46 | $613K | Direct | Jul 1, 2019 (0d) |
| Mar 1, 2019 | BGNE | ↓ Sell | 4,000 | $146.03 | $584K | Indirect | Mar 5, 2019 (4d) |
| Mar 1, 2019 | BGNE | ↓ Sell | 1,000 | $150.00 | $150K | Direct | Mar 5, 2019 (4d) |
| Dec 3, 2018 | BGNE | ↓ Sell | 5,000 | $152.41 | $762K | Direct | Dec 4, 2018 (1d) |
| Nov 19, 2018 | BGNE | ↓ Sell | 5,000 | $124.30 | $621K | Direct | Nov 21, 2018 (2d) |
| Aug 13, 2018 | BGNE | ↓ Sell | 3,449 | $158.77 | $548K | Direct | Aug 15, 2018 (2d) |
| Jul 12, 2017 | BGNE | ↓ Sell10b5-1 | 20,000 | $72.44 | $1.4M | Direct | Jul 13, 2017 (1d) |
| Jun 28, 2017 | BGNE | ↓ Sell | 35,000 | $44.95 | $1.6M | Direct | Jun 30, 2017 (2d) |
| Jun 2, 2017 | BGNE | ↓ Sell | 5,539 | $40.00 | $222K | Direct | Jun 6, 2017 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ONC insiders
Open-market trades in the last 12 months
About Xiaodong Wang's insider trades
Xiaodong Wang is a director at BeOne Medicines (ONC). Since Nov 23, 2016, Xiaodong has reported no open-market purchases and 56 sales worth $173.8M on SEC Form 4. In the last 12 months: 3 sales ($33.5M).
1 sale (1% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include gifts (15 filings), option exercises (13 filings), grants and awards (12 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ONC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.